Connect with us
The pharmaceutical company Eli Lilly has added that it will invest $100 million with the aim of boosting its footprint in the German biotechnology ecosystem. The...
Eli Lilly unites healthcare and research to create medicines that improve the lives of people around the world. Harnessing the power of biotechnology, chemistry, and genetics, its scientists are...
Teva initially got the chance to launch its drug called fremanezumab before Aimovig, but the opportunity slipped away when there was a delay in its FDA...